SciELO - Scientific Electronic Library Online

 
vol.23 issue1Understanding adherence in virally suppressed and unsuppressed human immunodeficiency virus-positive urban patients on second-line antiretroviral treatmentFuture approaches to clearing the latent human immunodeficiency virus reservoir: Beyond latency reversal author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Article

Indicators

Related links

  • On index processCited by Google
  • On index processSimilars in Google

Share


Southern African Journal of HIV Medicine

On-line version ISSN 2078-6751
Print version ISSN 1608-9693

Abstract

CHIRIMUTA, Linda A. Mandikiyana; PASCOE, Margaret J.  and  LOWE, Sara. Emergent dolutegravir resistance in integrase-naïve, treatment experienced patients from Zimbabwe. South. Afr. j. HIV med. (Online) [online]. 2022, vol.23, n.1, pp.1-3. ISSN 2078-6751.  http://dx.doi.org/10.4102/sajhivmed.v23i1.1435.

We report two cases of dolutegravir (DTG) resistance in highly treatment experienced patients. Monitoring for treatment failure and adherence support is important in highly treatment experienced patients taking DTG. What this study adds: Dolutegravir is the mainstay of HIV treatment programmes and emergence of drug resistance to DTG is of public health relevance.

Keywords : HIV drug resistance; dolutegravir; integrase strand inhibitor; antiretroviral treatment; HIV.

        · text in English     · English ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License